Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-30

Clinical Trial Update: Maintenance Azacitidine in Elderly Patients With Acute Myeloid Leukemia (AML) in CR After Induction Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating maintenance azacitidine in elderly patients with acute myeloid leukemia who achieved complete remission after induction chemotherapy. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2014-06-30